191 – 200 of 8593
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Highly multidrug-resistant Gram-negative bacterial infections in war victims in Ukraine, 2022
(
- Contribution to journal › Letter
-
Mark
A machine learning model for prediction of 30-day primary graft failure after heart transplantation
(
- Contribution to journal › Article
-
Mark
Conservative Management First Strategy in Aortic Vascular Graft and Endograft Infections
(
- Contribution to journal › Article
-
Mark
Knowledge, Attitude and Conspiracy Beliefs of Healthcare Workers in Lebanon towards Monkeypox
(
- Contribution to journal › Article
-
Mark
Mechanisms of a Mycobacterium tuberculosis Active Peptide
(
- Contribution to journal › Article
-
Mark
CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer
(
- Contribution to journal › Article
-
Mark
DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for Colorectal Cancer Patients
(
- Contribution to journal › Article
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Implications of antibiotics and antimicrobial resistance development during COVID-19 : questing genomic surveillance for a balancing act
2023) p.375-395(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection
(
- Contribution to journal › Article